IntegenX

Thermo Fisher said that IntegenX complements and enhances its existing human identification product portfolio.

The RapidHit ID instrument.

The new platform is smaller and less expensive than the company's first-generation forensic DNA platform, processing a single DNA sample in around 70 minutes.

Peter Vallone

Vallone recently authored a review of the field, noting that fully integrated rapid systems have special advantages.

Squad Car Profiling

Law enforcement agencies are enthusiastic about the potential for rapid DNA profiling, Mother Jones reports.

NEW YORK (GenomeWeb) – Human DNA identification firm IntegenX and Horizon Technology Finance said on Monday that IntegenX has secured a $10 million venture loan.

The University of Massachusetts has been awarded

NEW YORK (GenomeWeb) – Biometric solutions firm Morpho will market IntegenX's RapidHit DNA analysis system to law enforcement and government agencies in certain countries as part of a deal announced today.

NEW YORK (GenomeWeb News) – Human DNA identification technology company IntegenX today said it has earned ISO 9001:2008 certification for its quality management system.

A week after announcing 2013 revenues of $1.3 million — more than double its 2012 revenues — WaferGen Biosystems this week set a lofty goal of more than $5 million for its top line in 2014

IntegenX said this week that it has met Federal Bureau of Investigation guidelines to upload directly to the National DNA Index System (NDIS) known arrestee and convicted offender DNA profiles, as well as casework known samples, generated with the company's RapidHIT Syste

Pages

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.